Letter to the Editor. A Response to: Palliative Management of Inoperable Malignant Bowel Obstruction: Prospective, Open Label, Phase 2 Study at an NCI Comprehensive Cancer Center

J Pain Symptom Manage. 2024 Jun;67(6):e919-e920. doi: 10.1016/j.jpainsymman.2024.01.039. Epub 2024 Feb 10.

Authors

Katherine Clark¹, Jason W Boland², David C Currow³

Affiliations

¹ Palliative Care Network (K.C.), Northern Sydney Local Health District, Sydney, Australia; Northern Clinical School (K.C.), University of Sydney, New South Wales, Australia. Electronic address: Katherine.Clark@health.nsw.gov.au.
² Hull York Medical School (J.W.B.), University of Hull, Hull, United Kingdom.
³ Faculty of Science, Medicine and Health (D.C.C.), University of Wollongong, Wollongong, New South Wales, Australia.

PMID: 38342475
DOI: 10.1016/j.jpainsymman.2024.01.039

No abstract available

Publication types

Letter

MeSH terms

Clinical Trials, Phase II as Topic
Humans
Intestinal Obstruction* / etiology
Intestinal Obstruction* / therapy
Neoplasms / complications
Neoplasms / therapy
Palliative Care* / methods
Prospective Studies
Treatment Outcome